|
|
 | | | |
- close
- close
- close
- close
| |||||||||
This excerpt taken from the LUX 20-F filed Jun 25, 2009. Contributions — The
expected contributions for 2009 are expected to be immaterial for both the
Company and aggregate employee participants.
For 2008, an 11.0% (11.5% for 2007) increase in the cost of covered health care benefits was assumed. This rate was assumed to decrease gradually to 5% for 2020 and remain at that level thereafter. The health care cost trend rate assumption could have a significant effect on the amounts reported. A 1% increase or decrease in the health care trend rate would not have a material impact on the consolidated financial statements. The weighted-average discount rate used in determining the accumulated postretirement benefit obligation was 6.3% at December 31, 2008 and 6.5% at September 30, 2007.
The weighted-average discount rate used in determining the net periodic benefit cost for 2008 and 2007, was 6.5%, and 6.00%, respectively.
F-41 This excerpt taken from the LUX 6-K filed May 12, 2009. Contributions. The expected contributions for 2009 are
expected to be immaterial for both the Company and aggregate employee
participants.
For 2008, an 11.0% (11.5% for 2007) increase in the cost of covered health care benefits was assumed. This rate was assumed to decrease gradually to 5% for 2020 and remain at that level thereafter. The health care cost trend rate assumption could have a significant effect on the amounts reported. A 1% increase or decrease in the health care trend rate would not have a material impact on the consolidated financial statements. The weighted-average discount rate used in determining the accumulated postretirement benefit obligation was 6.3% at December 31, 2008 and 6.5% at September 30, 2007.
The weighted-average discount rate used in determining the net periodic benefit cost for 2008 and 2007, was 6.5%, and 6.00%, respectively.
This excerpt taken from the LUX 20-F filed Jun 26, 2008. Contributions — The
expected contributions for 2008 are Euro 0.2 million for the Company and Euro
0.1 million for the employee participants.
For 2007, a 11.5% (12% for 2006) increase in the cost of covered health care benefits was assumed. This rate was assumed to decrease gradually to 5% for 2020 and remain at that level thereafter. The health care cost trend rate assumption could have a significant effect on the amounts reported. A 1% increase or decrease in the health care trend rate would not have a material impact on the consolidated financial statements. The weighted-average discount rate used in determining the accumulated postretirement benefit obligation was 6.5% at September 30, 2007 and 6.0% at September 30, 2006.
The weighted average discount rate used in determining the net periodic benefit cost was 6.0% for 2007 and 5.75% for 2006.
F-37
This excerpt taken from the LUX 6-K filed Jun 4, 2008. Contributions. The expected
contributions for 2008 are Euro 0.2 million for the Company and Euro 0.1
million for the employee participants.
For 2007, a 11.5% (12% for 2006) increase in the cost of covered health care benefits was assumed. This rate was assumed to decrease gradually to 5% for 2020 and remain at that level thereafter. The health care cost trend rate assumption could have a significant effect on the amounts reported. A 1% increase or decrease in the health care trend rate would not have a material impact on the consolidated financial statements. The weighted-average discount rate used in determining the accumulated postretirement benefit obligation was 6.5% at September 30, 2007 and 6.0% at September 30, 2006.
The weighted average discount rate used in determining the net periodic benefit cost was 6.0% for 2007 and 5.75% for 2006.
This excerpt taken from the LUX 20-F filed Jun 29, 2007. Contributions—The expected contributions for 2007 are Euro 0.2
million for the Company and Euro 0.08 million for the employee participants.
For 2006, a 12% (10% for 2005) increase in the cost of covered health care benefits was assumed. This rate was assumed to decrease gradually to 5% for 2020 and remain at that level thereafter. The health care cost trend rate assumption could have a significant effect on the amounts reported. A 1% increase or decrease in the health care trend rate would not have a material impact on the consolidated financial statements. The weighted-average discount rate used in determining the accumulated postretirement benefit obligation was 6.0% at September 30, 2006 and 5.75% at September 30, 2005. The weighted-average discount rate used in determining the net periodic benefit cost for 2005 and 2006 was 5.75%, respectively. This excerpt taken from the LUX 6-K filed May 25, 2007. Contributions
- The expected contributions for 2007 are Euro 0.2 million for the Company and
Euro 0.08 million for the employee participants.
For 2006, a 12% (10% for 2005) increase in the cost of covered health care benefits was assumed. This rate was assumed to decrease gradually to 5% for 2020 and remain at that level thereafter. The health care cost trend rate assumption could have a significant effect on the amounts reported. A 1% increase or decrease in the health care trend rate would not have a material impact on the consolidated financial statements. The weighted-average discount rate used in determining the accumulated postretirement benefit obligation was 5.75% at September 30, 2005, and 6.0% at September 30, 2006. The weighted-average discount rate used in determining the net periodic benefit cost for 2005 and 2006 was 5.75%, respectively. This excerpt taken from the LUX 20-F filed Jun 28, 2006. Contributions—The expected contributions for 2005 are Euro
0.2 million for the Company and Euro 0.1 million for the employee
participants.
For 2005, a 10.0 percent (10.5 percent for 2004) increase in the cost of covered health care benefits was assumed. This rate was assumed to decrease gradually to 5 percent for 2015 and remain at that level thereafter. The health care cost trend rate assumption has a significant effect on the amounts reported. A 1.0 percent increase or decrease in the health care trend rate would have an immaterial impact on the consolidated financial statements. The weighted-average discount rate used in determining the accumulated post-retirement benefit obligation was 5.75 percent at September 30, 2004 and 6.00 percent at September 30, 2005. The weighted-average discount rate used in determining the net periodic benefit cost for 2004 and 2005 was 5.75 percent and 6.0 percent, respectively. Certain of the Company’s non-Italian and non-US subsidiaries provide limited non-pension benefits to retirees in addition to government sponsored programs. The cost of these programs is not significant to the Company. On December 8, 2003, the Medicare Prescription Drug Improvement and Modernization Act of 2003 (the “Act”) was signed into law. In accordance with FASB Staff Position 106-2, the Company’s measures of accumulated postretirement benefit obligation and net periodic benefit cost in the consolidated financial statements reflect the effects of the Act. The adoption of FASB Staff Position 106-2 did not have a material effect on the Company’s consolidated financial statements. | EXCERPTS ON THIS PAGE:
|
| |||||||
